Targeting SYK of monocyte-derived macrophages regulates liver fibrosis via crosstalking with Erk/Hif1α and remodeling liver inflammatory environment
Abstract Liver fibrosis is a danger signal indicating a huge risk of liver cancer occurrence, but there is still no effective clinical means to regulate the progress of liver fibrosis. Although a variety of drugs targeting SYK have been developed for tumors and autoimmune diseases, the mechanism and...
Guardado en:
Autores principales: | Xuejiao Chen, Ziyi Wang, Sheng Han, Zeng Wang, Yu Zhang, Xiangdong Li, Nan Xia, Wenjie Yu, Chenyang Jia, Yong Ni, Liyong Pu |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Publishing Group
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/abe1951af52e48a485781d8fef506221 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
ULK1 Suppresses Osteoclast Differentiation and Bone Resorption via Inhibiting Syk-JNK through DOK3
por: Yufeng Zhang, et al.
Publicado: (2021) -
Hepatic progenitors for liver disease: current position
por: Alice Conigliaro, et al.
Publicado: (2010) -
Monocytes secrete CXCL7 to promote breast cancer progression
por: Yi-Hsiang Wang, et al.
Publicado: (2021) -
PRMT3 promotes tumorigenesis by methylating and stabilizing HIF1α in colorectal cancer
por: Xin Zhang, et al.
Publicado: (2021) -
Initiation of hepatic stellate cell activation extends into chronic liver disease
por: Vincent De Smet, et al.
Publicado: (2021)